Author： Buddineni Jaya P Chaudhary Kunal Whaley-Connell Adam
Publisher： Future Medicine
ISSN： 1475-0708
Source： Therapy, Vol.8, Iss.2, 2011-03, pp. : 121-127
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New therapeutic agents for diabetic kidney disease
By Agrawal Varun Kizilbash Sani Haider McCullough Peter A
Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. :
Access to resources
Recommend
Diabetic Kidney Disease: Act Now or Pay Later
Nephron Clin Pract, Vol. 114, Iss. 3, 2010-02 ,pp. :
THE ROLE OF ALDOSTERONE ANTAGONISM AGENTS IN DIABETIC KIDNEY DISEASE
JOURNAL OF RENAL CARE, Vol. 41, Iss. 1, 2015-03 ,pp. :
Recurrence of diabetic kidney disease in a type 1 diabetic patient after kidney transplantation
NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. :
Is Cystatin C a Useful Marker in the Detection of Diabetic Kidney Disease?
Nephron Clin Pract, Vol. 114, Iss. 2, 2009-11 ,pp. :